Vicagrel
Metabolites
- Vicagrel is an oral antiplatelet agent developed to prevent thrombotic cardiovascular events by inhibiting platelet aggregation through P2Y12 receptor blockade. Reference standards of Vicagrel API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Vicagrel
[catalogue_number] => PA 22 1270000
[category_ids] => ,78,75,70,76,82,
[chemical_name] =>
[weight] => 379.86
[form] => C18H18ClNO4S
[cas] => 1314081-53-2
[pslug] => 1314081-53-2-vicagrel-pa221270000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 22 1270000
Molecular Formula : C18H18ClNO4S
Molecular Weight : 379.86